Research Topics
| Zdenek HelSummaryAffiliation: University of Alabama at Birmingham Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infectionZdenek Hel
Department of Pathology, University of Alabama at Birmingham, 845 19th Street South, Birmingham, Alabama 35294 2170, USA
Endocr Rev 31:79-97. 2010..This review summarizes current knowledge of the effects of various types of sex steroid hormones on immune processes involved in the biology of HIV-1 infection...
HIV infection: first battle decides the warZdenek Hel
Department of Pathology, University of Alabama at Birmingham, 619 19th Street South, Room SW W286, Birmingham, AL 35249 7331, USA
Trends Immunol 27:274-81. 2006....
Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infectionJiri Mestecky
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
J Reprod Immunol 83:196-200. 2009..Whether humoral responses to previously or newly encountered antigens are compromised in HIV-1-infected persons is under current investigation...
Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanismsRichard P H Huijbregts
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294 2182, USA
Endocrinology 154:1282-95. 2013..The presented results suggest that MPA suppresses both innate and adaptive arms of the immune system resulting in a reduction of host resistance to invading pathogens...
Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycationsWarren Denning
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294 2182, USA
Mol Biotechnol 53:308-14. 2013..In conclusion, various polycations and types of sera should be tested when optimizing lentiviral transduction of target cell populations...
A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in miceJun Xu
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294 2170, USA
J Virol Methods 158:70-6. 2009..In addition, using the newly defined epitopes, the relationship is described between the amount of plasmid DNA, volume of inoculate, and the extent of ensuing immune responses following intramuscular DNA immunization...
Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responsesMilan Raska
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294 2170, USA
Vaccine 26:1541-51. 2008..7% of CD8(+) splenocytes after in vitro stimulation with HIV-1 envelope peptides. These results demonstrate that DNA vaccines targeted to tissues with high proteosynthetic activity, such as the liver, results in enhanced immune responses...
Menstrual blood as a potential source of endometrial derived CD3+ T cellsSteffanie Sabbaj
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
PLoS ONE 6:e28894. 2011..These data may open new avenues of investigation for cell mediated immune studies involving the female reproductive tract without the need for biopsies...
Limited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responsesWarren L Denning
Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
PLoS ONE 6:e16897. 2011....
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levelsRanajit Pal
Advanced BioScience Laboratories, Inc, Kensington, Maryland 20895, USA
J Virol 80:3732-42. 2006..Thus, systemic immunization with ALVAC-HIV-1 vaccine candidates elicits anti-HIV-1 immune responses able to contain virus replication also at mucosal sites in macaques...
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responsesZdenek Hel
Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Immunol 169:4778-87. 2002..The results presented in this work also further demonstrate the potential of a DNA-prime/attenuated poxvirus-boost vaccine regimen in an animal model that well mirrors human AIDS...
A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccineZdenek Hel
Basic Research Laboratory, National Cancer Institute, 41 D804, Bethesda, MD 20892, USA
Vaccine 20:3171-86. 2002..No adverse effects were observed in either naive or SIV-infected rhesus macaques. Thus, an analogous HIV-1-based chimeric vaccine may represent useful component of an HIV-1 vaccine...
Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaquesZdenek Hel
Aventis-Pasteur, Ltd. 1755 Steeles Avenue West, Toronto, Ontario, M2R 3T4, Canada
Virology 304:125-34. 2002..Thus, both these vaccine modalities alone or in combination may be suitable candidate vaccines for immune therapy of HIV-1-infected individuals...
Immune intervention strategies for HIV-1 infection of humans in the SIV macaque modelGenoveffa Franchini
National Cancer Institute, Basic Research Laboratory, 41 D804, Bethesda, MD 20892 5055, USA
Vaccine 20:A52-60. 2002..Here, we will review the relative effect of ART and vaccination during primary SIVmac infection of macaques...
Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapyElzbieta Tryniszewska
Basic Research Laboratory, National Cancer Institute, Bethesda, MD 20892, USA
J Immunol 169:5347-57. 2002..These data provide the proof of concept that therapeutic vaccination before cessation of ART may be a feasible approach in the clinical management of HIV-1 infection...
Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251Liljana Stevceva
Animal Models and Retroviral Vaccines Section, Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
J Virol 76:9-18. 2002..Information on the quality and quantity of local immune responses may help in the design of vaccine strategies aimed at containing viral replication at the site of viral encounter...
Research Grants
- Dysregulation of IgA responses in HIV-1-infected individualsZdenek Hel; Fiscal Year: 2007....
- Dysregulation of IgA responses in HIV-1-infected individualsZdenek Hel; Fiscal Year: 2009....
- Dysregulation of IgA responses in HIV-1-infected individualsZdenek Hel; Fiscal Year: 2010....
